Biotechnology Based Process for Production of a Disulfide-Bridged Peptide
A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and 12 natural amino acids joined by a disulfide bond at the N-terminal end. An efficient biotechnology based process for the production of the disulfide-bridged peptide was developed. Initially, the two...
Saved in:
Published in: | Bioconjugate chemistry Vol. 27; no. 5; pp. 1276 - 1284 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Chemical Society
18-05-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and 12 natural amino acids joined by a disulfide bond at the N-terminal end. An efficient biotechnology based process for the production of the disulfide-bridged peptide was developed. Initially, the two individual oligopeptide chains were prepared separately by designing different fusion proteins and expressing them in recombinant E. coli. Enzymatic or chemical cleavage of the two fusion proteins provided the two individual oligopeptide chains which could be conjugated via disulfide bond by conventional chemical reaction to the disulfide-bridged peptide. A novel heterodimeric system to bring the two oligopeptide chains closer and induce disulfide bond formation was designed by taking advantage of the self-assembly of a leucine zipper system. The heterodimeric approach involved designing fusion proteins with the acidic and basic components of the leucine zipper, additional amino acids to optimize interaction between the individual chains, specific cleavage sites, specific tag to ensure separation, and two individual oligopeptide chains. Computer modeling was used to identify the nature and number of amino acid residue to be inserted between the leucine zipper and oligopeptides for optimum interaction. Cloning and expression in rec E. coli, fermentation, followed by cell disruption resulted in the formation of heterodimeric protein with the interchain disulfide bond. Separation of the desired heterodimeric protein, followed by specific cleavage at methionine by cyanogen bromide provided the disulfide-bridged peptide. |
---|---|
AbstractList | A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and 12 natural amino acids joined by a disulfide bond at the N-terminal end. An efficient biotechnology based process for the production of the disulfide-bridged peptide was developed. Initially, the two individual oligopeptide chains were prepared separately by designing different fusion proteins and expressing them in recombinant E. coli. Enzymatic or chemical cleavage of the two fusion proteins provided the two individual oligopeptide chains which could be conjugated via disulfide bond by conventional chemical reaction to the disulfide-bridged peptide. A novel heterodimeric system to bring the two oligopeptide chains closer and induce disulfide bond formation was designed by taking advantage of the self-assembly of a leucine zipper system. The heterodimeric approach involved designing fusion proteins with the acidic and basic components of the leucine zipper, additional amino acids to optimize interaction between the individual chains, specific cleavage sites, specific tag to ensure separation, and two individual oligopeptide chains. Computer modeling was used to identify the nature and number of amino acid residue to be inserted between the leucine zipper and oligopeptides for optimum interaction. Cloning and expression in rec E. coli, fermentation, followed by cell disruption resulted in the formation of heterodimeric protein with the interchain disulfide bond. Separation of the desired heterodimeric protein, followed by specific cleavage at methionine by cyanogen bromide provided the disulfide-bridged peptide. |
Author | Doyle, Richard Lyngberg, Olav K Johnston, Robert M Krystek, Stanley R Witmer, Mark Bryson, James W Lo, Ehrlic Chan, Steven H Calambur, Deepa Goldberg, Steven L Gao, Mian Ramirez, Antonio Wan, Changhong Hanson, Ronald L Goswami, Animesh de Mas, Nuria Kim, Yeoun jin Ding, Wei Chan, Yeung |
AuthorAffiliation | Chemical Development Operations Discovery Bristol-Myers Squibb Analytical and Bioanalytical Development Chemical Development |
AuthorAffiliation_xml | – name: Chemical Development Operations – name: – name: Analytical and Bioanalytical Development – name: Bristol-Myers Squibb – name: Discovery – name: Chemical Development |
Author_xml | – sequence: 1 givenname: Animesh surname: Goswami fullname: Goswami, Animesh email: animesh.goswami@bms.com – sequence: 2 givenname: Steven L surname: Goldberg fullname: Goldberg, Steven L – sequence: 3 givenname: Ronald L surname: Hanson fullname: Hanson, Ronald L – sequence: 4 givenname: Robert M surname: Johnston fullname: Johnston, Robert M – sequence: 5 givenname: Olav K surname: Lyngberg fullname: Lyngberg, Olav K – sequence: 6 givenname: Yeung surname: Chan fullname: Chan, Yeung – sequence: 7 givenname: Ehrlic surname: Lo fullname: Lo, Ehrlic – sequence: 8 givenname: Steven H surname: Chan fullname: Chan, Steven H – sequence: 9 givenname: Nuria surname: de Mas fullname: de Mas, Nuria – sequence: 10 givenname: Antonio surname: Ramirez fullname: Ramirez, Antonio – sequence: 11 givenname: Richard surname: Doyle fullname: Doyle, Richard – sequence: 12 givenname: Wei surname: Ding fullname: Ding, Wei – sequence: 13 givenname: Mian surname: Gao fullname: Gao, Mian – sequence: 14 givenname: Stanley R surname: Krystek fullname: Krystek, Stanley R – sequence: 15 givenname: Changhong surname: Wan fullname: Wan, Changhong – sequence: 16 givenname: Yeoun jin surname: Kim fullname: Kim, Yeoun jin – sequence: 17 givenname: Deepa surname: Calambur fullname: Calambur, Deepa – sequence: 18 givenname: Mark surname: Witmer fullname: Witmer, Mark – sequence: 19 givenname: James W surname: Bryson fullname: Bryson, James W email: james.bryson@bms.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27098672$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkclOwzAURS1URAf4BYjEhk2Kh8TDkpapUiVYdB8lznObKo2LnSz69zhqGcSGla-l8671fMZo0NgGELoheEowJfe59tOisto2W72B3ZQXGBNMztCIpBTHiSR0EDJOWEwkpkM09n6LMVZE0gs0pAIryQUdocWssi3oTWNruz5Es9xDGb07q8H7yFjX57LTbWWbyJoojx4r39WmKiGeuapc9zTs23C_ROcmrz1cnc4JWj0_reav8fLtZTF_WMY540kbU14WJWHGSJpCCUJRAKUKIbgBGkKqNBYMuM5TAgRoYSiwhKYpLZTihE3Q3bF27-xHB77NdpXXUNd5A7bzWVhXci6k5P-jQoVfE4mkAb39g25t55qwR08xJlIskkCJI6Wd9d6Byfau2uXukBGc9V6y4CX75SU7eQmT16f-rthB-T33JSIA7Aj0DT9v_1P7CW_En3g |
Cites_doi | 10.1110/ps.39401 10.1385/1-59259-169-8:485 10.1016/S0021-9258(18)61965-9 10.1006/abio.1998.2945 10.1016/S0021-9673(00)93969-4 10.1002/cbic.200300781 10.1016/j.pep.2003.07.001 10.1016/0958-1669(95)80083-2 10.1006/prep.1997.0767 10.1007/BF00168477 10.1038/nbt1188-1321 10.1002/bip.21492 10.1042/bj3380077 10.1016/0960-9822(93)90063-T 10.1161/CIRCULATIONAHA.107.759167 10.1073/pnas.0509880103 10.1016/j.bej.2010.06.013 10.1002/jmr.555 10.1111/j.1432-1033.1989.tb15245.x 10.1021/bp00018a001 10.1016/1046-5928(91)90057-P 10.1007/s00253-002-1158-6 10.1073/pnas.91.24.11408 10.1038/nbt0487-379 10.1006/abio.1998.3084 10.1016/j.pep.2004.04.020 10.1110/ps.8.8.1668 10.1016/S0076-6879(72)25037-6 10.1042/bj2400001 10.1016/0968-0004(89)90133-3 |
ContentType | Journal Article |
Copyright | Copyright © 2016 American Chemical Society Copyright American Chemical Society May 18, 2016 |
Copyright_xml | – notice: Copyright © 2016 American Chemical Society – notice: Copyright American Chemical Society May 18, 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QO 7TM 8FD FR3 P64 7X8 |
DOI | 10.1021/acs.bioconjchem.6b00101 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Biotechnology Research Abstracts Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Engineering Research Database Biotechnology Research Abstracts Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Engineering Research Database MEDLINE - Academic Engineering Research Database |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1520-4812 |
EndPage | 1284 |
ExternalDocumentID | 4075713221 10_1021_acs_bioconjchem_6b00101 27098672 b212233107 |
Genre | Journal Article Feature |
GroupedDBID | - 23N 53G 55A 5GY 7~N AABXI ABMVS ABUCX ACGFS ACIWK ACJ ACPRK ACS AEESW AENEX AFEFF AFRAH ALMA_UNASSIGNED_HOLDINGS AQSVZ CS3 DU5 EBS ED ED~ EJD F5P GNL IH9 JG JG~ LG6 P2P PQEST PQQKQ ROL TN5 TWZ UI2 VF5 VG9 W1F X XKZ YZZ --- -~X 4.4 5VS ABJNI ABQRX ADHLV AGXLV AHGAQ BAANH CGR CUPRZ CUY CVF ECM EIF GGK NPM AAYXX CITATION 7QO 7TM 8FD FR3 P64 7X8 |
ID | FETCH-LOGICAL-a364t-26dbd13ff825ede792ee99b776fe299b59c073e6ca51e1e2bf2e342552b99613 |
IEDL.DBID | ACS |
ISSN | 1043-1802 |
IngestDate | Fri Aug 16 03:45:19 EDT 2024 Fri Aug 16 22:32:11 EDT 2024 Thu Oct 10 19:31:42 EDT 2024 Fri Aug 23 00:39:15 EDT 2024 Sat Sep 28 08:49:00 EDT 2024 Thu Aug 27 13:42:05 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a364t-26dbd13ff825ede792ee99b776fe299b59c073e6ca51e1e2bf2e342552b99613 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 27098672 |
PQID | 1793375074 |
PQPubID | 45565 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1808667886 proquest_miscellaneous_1790017482 proquest_journals_1793375074 crossref_primary_10_1021_acs_bioconjchem_6b00101 pubmed_primary_27098672 acs_journals_10_1021_acs_bioconjchem_6b00101 |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 XKZ 7~N ACJ VG9 W1F ACS AEESW AFEFF ABMVS ABUCX IH9 AQSVZ ED~ UI2 |
PublicationCentury | 2000 |
PublicationDate | 2016-05-18 |
PublicationDateYYYYMMDD | 2016-05-18 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-18 day: 18 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Washington |
PublicationTitle | Bioconjugate chemistry |
PublicationTitleAlternate | Bioconjugate Chem |
PublicationYear | 2016 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref9/cit9 ref6/cit6 ref3/cit3 Maroux S. (ref18/cit18) 1971; 246 ref27/cit27 Smith B. J. (ref22/cit22) 2002 ref11/cit11 ref25/cit25 ref16/cit16 ref29/cit29 ref32/cit32 ref23/cit23 ref14/cit14 ref8/cit8 ref5/cit5 ref31/cit31 ref2/cit2 ref28/cit28 ref20/cit20 ref17/cit17 ref10/cit10 ref26/cit26 ref19/cit19 ref21/cit21 ref12/cit12 ref15/cit15 ref13/cit13 ref33/cit33 ref4/cit4 ref30/cit30 ref1/cit1 ref24/cit24 ref7/cit7 |
References_xml | – ident: ref29/cit29 doi: 10.1110/ps.39401 – ident: ref2/cit2 – start-page: 485 volume-title: The protein protocols handbook year: 2002 ident: ref22/cit22 doi: 10.1385/1-59259-169-8:485 contributor: fullname: Smith B. J. – volume: 246 start-page: 5031 year: 1971 ident: ref18/cit18 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)61965-9 contributor: fullname: Maroux S. – ident: ref33/cit33 doi: 10.1006/abio.1998.2945 – ident: ref14/cit14 doi: 10.1016/S0021-9673(00)93969-4 – ident: ref21/cit21 – ident: ref30/cit30 doi: 10.1002/cbic.200300781 – ident: ref24/cit24 doi: 10.1016/j.pep.2003.07.001 – ident: ref8/cit8 doi: 10.1016/0958-1669(95)80083-2 – ident: ref10/cit10 doi: 10.1006/prep.1997.0767 – ident: ref9/cit9 doi: 10.1007/BF00168477 – ident: ref15/cit15 doi: 10.1038/nbt1188-1321 – ident: ref4/cit4 doi: 10.1002/bip.21492 – ident: ref12/cit12 doi: 10.1042/bj3380077 – ident: ref27/cit27 doi: 10.1016/0960-9822(93)90063-T – ident: ref1/cit1 doi: 10.1161/CIRCULATIONAHA.107.759167 – ident: ref3/cit3 – ident: ref31/cit31 doi: 10.1073/pnas.0509880103 – ident: ref32/cit32 doi: 10.1016/j.bej.2010.06.013 – ident: ref11/cit11 doi: 10.1002/jmr.555 – ident: ref16/cit16 doi: 10.1111/j.1432-1033.1989.tb15245.x – ident: ref23/cit23 doi: 10.1021/bp00018a001 – ident: ref7/cit7 doi: 10.1016/1046-5928(91)90057-P – ident: ref17/cit17 doi: 10.1007/s00253-002-1158-6 – ident: ref28/cit28 doi: 10.1073/pnas.91.24.11408 – ident: ref6/cit6 doi: 10.1038/nbt0487-379 – ident: ref20/cit20 doi: 10.1006/abio.1998.3084 – ident: ref26/cit26 doi: 10.1016/j.pep.2004.04.020 – ident: ref13/cit13 doi: 10.1110/ps.8.8.1668 – ident: ref25/cit25 doi: 10.1016/S0076-6879(72)25037-6 – ident: ref5/cit5 doi: 10.1042/bj2400001 – ident: ref19/cit19 doi: 10.1016/0968-0004(89)90133-3 |
SSID | ssj0009182 |
Score | 2.2191954 |
Snippet | A disulfide-bridged peptide drug development candidate contained two oligopeptide chains with 11 and 12 natural amino acids joined by a disulfide bond at the... |
SourceID | proquest crossref pubmed acs |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1276 |
SubjectTerms | Amino Acid Sequence Biotechnology Chemical reactions Clinical trials Disulfides - chemistry E coli Escherichia coli Escherichia coli - genetics Models, Molecular Peptides Peptides - chemistry Peptides - genetics Peptides - metabolism Protein Multimerization Protein Structure, Quaternary |
Title | Biotechnology Based Process for Production of a Disulfide-Bridged Peptide |
URI | http://dx.doi.org/10.1021/acs.bioconjchem.6b00101 https://www.ncbi.nlm.nih.gov/pubmed/27098672 https://www.proquest.com/docview/1793375074 https://search.proquest.com/docview/1790017482 https://search.proquest.com/docview/1808667886 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8QwDLZ4CMHC-3E8g4SYKFzSNE1H7oFgYYGBrUoaVzoEPUTvBv49Tts7YAAEW5SkbWK7sb_YcQBOEE3kbBYFwsZxQEIhgiRyJohyqTk1Yq794eTru_j2Qff6Pk0O_8aDL_iFycpzOxgSOnykaTyfqwrHEOCZFzHZC94a6t595NnlunZw-syb2gfvHP3yIq-WsvKrWvrG1qx0ztXKP0a7CsuNgckua4lYgxks1mHjsiBw_fzGTlkV8lntpa_DQmdSWuxOLn7bgBuqHU133FmH9JxjzYECRjauL7s66Swb5syw3qAcP-UDh0GnOv5FvX2sjMNNuL_q33evg-bGhcCESo4CoZx1PMxzwo3oME4EYpIQF1WOpLdslGS0JKDKTMSRo7C5wJAYHAlLuImHWzBXDAvcAWaVQelQyowAV4g2cUls21IS3ONtbbIWnBGp0uaHKdPKFy546is_0S9t6NeC9oQ96UudhuP3R_YnbPz0GVqOQjKSYtmC42kz0de7SUyBw3HVx-tuqcUPfTRBQdLzWrVguxaR6bhILBOtYrH7tynuwRIZY8pHJnC9D3Oj1zEewGzpxoeViL8DqRT7RQ |
link.rule.ids | 315,782,786,2769,27085,27933,27934,56747,56797 |
linkProvider | American Chemical Society |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFH_amCa48DlYoYCRpp0Iqx3HcY60BRUNuNDDblEcv0idaDot7WH_Pc9OUtgBENwsx3Hs5xe_9_P7MMA3xCyyJo8CYeI4IKYQQRLZLIgKqTk9xEK74OTRXXz7Sw8vXJoc3cbC0CAq6qnyRvzH7AL8h6szkxmBxN80m-mZ8nCGcM-nSJFK7JSiwd1jul2uazunS8CpnQ_P8SsdOemUV_9Lp2dUTi96LjfeP-hNWG_UTXZe88cWfMByG3bOS4La03_sO_MOoP5kfRs-99vS6qC9Bm4Hrqh2vjx_Z32SepY14QWMNF5XtnUKWjYrWMaGk2pxX0wsBn0fDEatneeMxS8wvrwYD0ZBc_9CkIVKzgOhrLE8LApCkWgxTgRiktCaqgJJipkoyWmDQJVnEUeOwhQCQ1ruSBhCUTzchZVyVuJXYEZlKC1KmRP8CtEkNolNT0oCf7yns7wDp0SqtPl9qtRbxgVPXeUT-qUN_TrQa1cp_VMn5Xj9lW67mk8-Q5tTSCpTLDtwsnxM9HVGk6zE2cK3cZJcavFCG03AkKS-Vh3YqzllOS4R9xKtYrH_tikew-pofHOdXl_d_jyANVLTlPNZ4LoLK_O_CzyEj5VdHHmufwBK3wPB |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BEY8Lj5bHQqFGQpxIWTuOHxKXfXTVClQhtQduURyPpUU0W5HdA_-esZMs5QAV4mbZjmPP2J75POMxwBvEqvCuLjLhtM5oUojMFr7KiiANp0IMJl5OPj7Tp1_M_CiGyfkw3IWhTrTUUpuM-HFVX_rQRxjg72O-W64IKH6lEV0cqgRpCPvcKpS2EXpNZme_Qu5y09k6YxBOE_14Dq5pKEqouv1dQv1B7UziZ_Hg_zr-EO73aiebdPPkEdzAZhf2Jg1B7osf7C1LjqDphH0Xbk-H1N3Z8BzcHpxQ7np7Ds-mJP08668ZMNJ8Y9p3oWjZKrCKzZft5ltYesym6VIY1Y4eNB4fw_ni6Hx2nPXvMGRVruQ6E8o7z_MQCE2iR20ForXEWxWQpJkrbE0bBaq6KjhyFC4IzInthXCEpnj-BHaaVYPPgDlVofQoZU0wLEdnvdVuLCWBQD42VT2Cd0Sqsl9GbZks5IKXMfMK_cqefiMYD5wqL7vgHNd_sj9w9MpvaJPKSXXScgSvt8VE32g8qRpcbVKdKNGlEX-pYwggkvQ3agRPu9my7ZfQY2uUFs__bYgHcOfzfFF-Ojn9-ALukbamousCN_uws_6-wZdws_WbV2ni_wS2rwZE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biotechnology+Based+Process+for+Production+of+a+Disulfide-Bridged+Peptide&rft.jtitle=Bioconjugate+chemistry&rft.au=Goswami%2C+Animesh&rft.au=Goldberg%2C+Steven+L&rft.au=Hanson%2C+Ronald+L&rft.au=Johnston%2C+Robert+M&rft.date=2016-05-18&rft.eissn=1520-4812&rft.volume=27&rft.issue=5&rft.spage=1276&rft.epage=1284&rft_id=info:doi/10.1021%2Facs.bioconjchem.6b00101&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-1802&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-1802&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-1802&client=summon |